- News, Events, & Media Archive
Press Releases
Events
San Francisco, CA (DIGITAL)
June 25, 2020
twoXAR Pharmaceuticals CEO, Andrew A. Radin, joins a panel on "What's Next: Investment, Partnerships, and Pushing Life Sciences Forward"
Digital Meeting
June 8-12, 2020twoXAR CEO Andrew Radin discusses how the company approaches drug discovery.
Digital
May 19, 2020
twoXAR Pharmaceuticals VP Discovery, Aaron Daugherty, joins DrugBank CEO Michael Wilson in an online fireside chat on using DrugBank data sources for drug discovery.
Paris, France - CHANGED TO FULL DIGITAL EVENT
March 23-25, 2020twoXAR Pharmaceuticals CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.
New York, NY
February 10-11, 2020
twoXAR Pharmaceuticals CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.
Tokyo, Japan
January 24, 2020
Join twoXAR CEO, Andrew A. Radin and Senior VP of Business Development, Allen Poirson, for an opportunity to meet with MIT-connected startups and hear about their impactful work and technology.
San Francisco, CA
January 13, 2020
twoXAR CEO, Andrew A. Radin, participates in a panel discussion: Every Healthcare Professionals Dream: AI in Data, Diagnosis and Patient Care.
San Francisco, CA
January 12, 2020
twoXAR CEO, Andrew A. Radin, participates in a panel discussion on AI and Digital Health.
Boston, MA
December 10, 2019
twoXAR CEO, Andrew A. Radin, participates in a startup lightning talk about twoXAR and discovering pharmaceuticals with AI.
London, UK
November 19-20, 2019
twoXAR VP Discovery, Aaron Daugherty, discusses the applications of AI in Drug Discovery.
London, UK
November 11-12, 2019
twoXAR CEO, Andrew A. Radin, joins a panel discussion on 'Digital R&D: AI - The Reckoning?'
Yokohama, Japan
May 26-28, 2019
twoXAR Co-Founder, Andrew M. Radin, discusses Recent IP and Business Trends in Advanced Drug Discovery Technology panel with Ichiro Nakatomi, S. Roy Kimura, Patrick Reid, Rob Garbaccio.
2019 MIT Startup Showcase Japan
Takeda Shonan Research Center, Japan
May 23, 2019
twoXAR Co-Founder, Andrew M. Radin, discusses the applications of AI in Drug Discovery.
Tokyo, Japan
April 18, 2019
twoXAR CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.
Cambridge, MA
December 4-5, 2018
twoXAR Co-Founder, Andrew M. Radin, discusses artificial intelligence in drug discovery.
London, UK
November 26-27, 2018
twoXAR CEO, Andrew A. Radin, discusses artificial intelligence in drug discovery and how it's impacting the discovery of novel ophthalmology therapeutics.
Boston, MA
October 25-26, 2018twoXAR CEO, Andrew A. Radin, speaks on AI Applications for Identifying New Drug Candidates panel with Saurabh Saha and Ramesh Durvasula.
Seoul, Korea
October 15, 2018
twoXAR Co-Founder, Andrew M. Radin, presents Discovering, Validating, & Launching First-In-Class Therapeutic Programs in 4 Months.
Oxford, UK
September 27, 2018twoXAR Co-Founder, Andrew M. Radin, discusses artificial intelligence in drug discovery.
Seoul, Korea
September 6-7, 2018
twoXAR Co-Founder, Andrew M. Radin, presents Partnering in AI-Driven Drug Development.
Tokyo, Japan
July 19-20, 2018twoXAR Co-Founders Andrew A. and Andrew M. share the twoXAR story and how AI is accelerating drug discovery.
New York, NY
May 10, 2018
twoXAR CEO, Andrew A. Radin, speaks on AI, Robotics, Blockchain and the Digital Transformation of Healthcare and Life Sciences panel with Ashish Atreja, John Baldoni, Eric Perakskis, & Tom Stanis.
Menlo Park, CA
March 15, 2018
twoXAR CEO, Andrew A. Radin, speaks on The New Machines of Industry - Buy, Build or Partner: Manufacturing, IoT & AI panel with Marianne Wu, & Sangbae Kim.
Mountain View, CA
January 22-24, 2018twoXAR CEO, Andrew A. Radin, presents How AI is Helping Find Better Medicines.
Takeda Shonan Research Center, Japan
October 18, 2017
twoXAR Chief Marketing Officer, Andrew M. Radin, discusses artificial intelligence in drug discovery.
San Francisco, CA
June 26-27, 2017twoXAR CEO, Andrew A. Radin, speaks on Accelerating Drug Discovery and Research with AI panel with Abraham Heifets, Vijay Pande, & Marina Sirota.
Washington, DC
May 12-16, 2017
twoXAR Senior Scientist, Aaron Daugherty, presents An Integrative Bioinformatics Approach Identifies In Vivo Validated Drug Candidates with Novel Mechanisms of Action in Rheumatoid Arthritis poster.
Palo Alto, CA
April 24, 2017
twoXAR Senior Scientist, Aaron Daugherty, presents An Integrative Bioinformatics Approach Identifies In Vivo Validated Drug Candidates with Novel Mechanisms of Action in Rheumatoid Arthritis poster.
253rd American Chemical Society - National Meeting & Exposition
San Francisco, CA
April 2-6, 2017
twoXAR CEO, Andrew A. Radin, speaks on Big Data and Pharmaceutical Innovation panel with Craig Mak & Van Willis.
Palm Springs, CA
November 30 - December 2, 2016
twoXAR CEO, Andrew A. Radin, presents What if new medications could be found in minutes instead of years?
Berkeley, CA
October 9 - 11, 2016
twoXAR CEO, Andrew A. Radin, speaks on Driving Life Science Research Through Data Science panel with Brian Naughton, Vijay Pande, & Zach Serber.
Seoul, South Korea
May 18, 2016
twoXAR Chief Business Officer, Andrew M. Radin, discusses starting up from universities: MIT & Stanford.
San Francisco, CA
October 5, 2015
twoXAR CEO, Andrew A. Radin, speaks on From the Horse's Mouth: What Happens When Digital Meets Pharma? panel with Anthony Costello, Chris Hogg, & Carlos Rodarte.
Cambridge, MA
September 16, 2015
twoXAR CEO, Andrew A. Radin, presents at 2015 MIT Digital Health Conference.
Sanofi Big Data Symposium: Convergence of Science, Technology & Data Sciences – Impact on Pharma
Cambridge, MA
June 29-30, 2015
twoXAR CEO, Andrew A. Radin,discusses the impact of big data on drug discovery.
Cambridge, MA
February 26, 2015twoXAR CEO, Andrew A. Radin, speaks on Big Data Policy & Personalized Medicine panel with Dr. Khaled El Emam, Dan Meyer, & Nate Russell.
Feature Articles
Targeted Oncology
June 26, 2020
BioWorld
April 3, 2019
Business Insider
March 19, 2018Stanford Medicine
December 9, 2016
FierceBiotech
September 12, 2016Pharmaceutical Executive
September 1, 2016GenomeWeb
December 1, 2015San Francisco Business Times
August 31, 2015Media Mentions
Frost & Sullivan
June 9, 2020
Los Angeles Times
January 3, 2016GenomeWeb
December 31, 2015Drug Discovery & Development
December 4, 2015FierceBiotech
November 20, 2015Wall Street Journal
November 18, 2015Business Insider
November 18, 2015
MedCityNews
November 18, 2015Andrew A. Radin, CEO - TEDMED 2016
Webinars, Podcasts, & Videos
Contagion Live
June 18, 2020Moneyball Medicine Podcast
October 14, 2018
ShareVault
October 12, 2017a16z Podcast
June 14, 2016
The Bio Report Podcast
October 27, 2016
TBWA\WorldHealth
January 23, 2017Publications & Posters
Isaac Hakim, Mei-Sze Chua, Wei Wei, Li Ma, Samuel So, Elizabeth Noblin, Sana Mujahid, Aaron C. Daugherty, and Timothy S. Heuer
Isaac Hakim, Sana Mujahid, Aaron C Daugherty and Timothy S Heuer
Yen S Low, Aaron C Daugherty, Elizabeth A Schroeder, William Chen, Tina Seto, Susan Weber, Michael Lim, Trevor Hastie, Maya Mathur, Manisha Desai, Carl Farrington, Andrew A Radin, Marina Sirota, Pragati Kenkare, Caroline A Thompson, Peter P Yu, Scarlett L Gomez, George W Sledge Jr, Allison W Kurian, Nigam H Shah. Journal of the American Medical Informatics Association. EPub: December 9, 2016Aaron C Daugherty, Carl Farrington, Isaac Hakin, Sana Mujahid, Elizabeth S Noblin, Andrew M Radin, Mei-Sze Chua, Mark Rabe, Guy Fernald, Daniel Ford, Marina Sirota, Laura Schaevitz, Andrew A Radin. bioRxiv 243998; doi: https://doi.org/10.1101/243998Poster: An Integrative Bioinformatics Approach Identifies In Vivo Validated Drug Candidates with Novel Mechanisms of Action in Rheumatoid Arthritis
Aaron C Daugherty1, Carl Farrington1, Isaac Hakim1, Elizabeth S Noblin1, Andrew M Radin1, Mei-Sze Chua2, Mark Rabe3, Guy Fernald3, Daniel Ford3, Marina Sirota4, Laura Schaevitz3, Andrew A Radin1
1twoXAR, 2Stanford University School of Medicine, 3Vium, 4UCSF
© 2020 twoXAR, Incorporated | All Rights Reserved